American Academy of Orthopedic Surgeons. Treatment of Osteoarthritis of the Knee 2nd edition. 2011; Available at: https://www.aaos.org/research/guidelines/OAKSummaryofRecommendations.pdf
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC, American Psychiatric Association. 2013 page 541.
Babor TF, de la Fluente JF, Saunders J, Grant M. AUDIT: The Alcohol Use Disorders Identification Test: guidelines for use in primary health care. Geneva, Switzerland: World Health Organization. 1992.
Bates D, Schultheis BC, Hanes MC, et al. <i>A Comprehensive Algorithm for Management of Neuropathic Pain</i>. <i>Pain Med</i>. 01 2019;20(Suppl 1):S2-S12. PMCID: PMC6544553</a>. PMID: 31152178</a>.
Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Review. 1988; 8(1):77-100.
Belgrade M, Schamber CD, Lindgren BR. The DIRE score. Predicting outcomes of opioid prescribing for chronic pain. The Journal of Pain. 2006; 7(9): 671-81. Available at: http://www.jpain.org/article/S1526-5900(06)00626-2/abstract. Accessed on: 2017-04-10.
Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016. MMWR Recomm Rep. 2016; ePub: March 2016: DOI: http://dx.doi.org/10.15585/mmwr.rr6501e1er. Available at: https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm. Accessed on: 2017-04-10.
FDA. Drug Safety and Availability – FDA Drug Safety Communication: FDA recommends against the continued use of propoxyphene. https://www.fda.gov/Drugs/DrugSafety/ucm234338.htm. Accessed April 7, 2017.
FSMB. Model Policy on DATA 2000 and Treatment of Opioid Addiction in the Medical Office. FSMB Website http://www.fsmb.org. 2013. Available at: https://www.fsmb.org/Media/Default/PDF/FSMB/Advocacy/2013_model_policy_treatment_opioid_addiction.pdf Accessed on: 2017-05-23.
HHS. HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics. September 2019. https://www.hhs.gov/opioids/sites/default/files/2019-10/Dosage_Reduction_Discontinuation.pdf
Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann. Rheum. Dis. 2000;16 (4): 494-502. Available at https://www.ncbi.nlm.nih.gov/pubmed/13498604. Accessed 5/29/2017.
Kraus ML, Alford DP, Kotz MM, et al. Statement of the American Society of Addiction Medicine Consensus Panel on the Use of Buprenorphine in Office-Based Treatment of Opioid Addiction.. Journal of Addiction Medicine. 2011; 5(4): 254-263. Available at: http://www.asam.org/docs/advocacy/use-of-buprenorphine-in-office-based-treatment-of-opioid-addiction.pdf Accessed on: 2017-05-23.
Krebs EE, Lorenz KA, Bair MJ. Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med. 2009; 24(6): 733-738. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686775/ Accessed on: 2017-04-10.
Kumar L, Barker C, Emmanuel A. Opioid-induced constipation: Pathophysiology, clinical consequences, and management. Gastroenterology Research and Practice. 2014; 2014. Available at: https://www.hindawi.com/journals/grp/2014/141737/.
Marshall, PS. Physical Functional Ability Questionnaire (FAQ5). In: Assessment and Management of Chronic Pain, 5th edition. Institute for Clinical Systems Improvement. 2011; 14: Appendix C:99. Available at: http://www.generationsprimarycare.com/assets/pain-contract.pdf Accessed on: 2017-04-10.
Merrill JO, Von Korff M, Banta-Green CJ, et al. Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients. General Hospital Psychiatry. 2012; 34: 581-587. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22959422 Accessed on: 2017-04-17.
Pani PP, Vacca R, Troqu E, Amato L, Davoli M. Pharmacological treatment for depression during opioid agonist treatment for opioid dependence. Cochrane Database of Systematic Reviews. 2010; 8(9): CD008373. Available at: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008373.pub2/abstract Accessed on: 2017-04-10.
Passik SD, Kirsh KL, Whitcomb, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. 2004. Clin Ther.; 26(4):552-61. https://www-ncbi-nlm-nih-gov.libproxy.lib.unc.edu/pubmed/15189752 PMID: 15189752
PCSS-MAT/APA. Opioid use disorder diagnostic criteria. Reprinted from Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, (Copyright 2013) American Psychiatric Association. Available at: http://pcssmat.org/wp-content/uploads/2014/02/5B-DSM-5-Opioid-Use-Disorder-Diagnostic-Criteria.pdf Accessed on: 2017-04-10.
SAMHSA. “Buprenorphine.” Text. SAMHSA, updated 4/27/2021. https://www.samhsa.gov/medication-assisted-treatment/treatment/buprenorphine
Substance Abuse and Mental Health Services Administration. Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update. Advisory. Winter 2016; 15 (1): . Available at: http://store.samhsa.gov/shin/content//SMA16-4938/SMA16-4938.pdf Accessed on: 2016-03-05.
Substance Abuse and Mental Health Services Administration. What Individuals in Recovery Need to Know About Wellness. 2016: Available at: http://store.samhsa.gov/shin/content//SMA16-4950/SMA16-4950.pdf Accessed on: 2016-08-30.
Sheng J, Liu S, Wang Y, Cui R, Zhang X. The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain. Neural Plast. 2017;2017. PMCID: PMC5494581. PMID: 2
Webster LR. Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the opioid risk tool. Pain Medicine. 2005;6(6):432-442. Available at: https://www.ncbi.nlm.nih.gov/pubmed/16336480. Accessed on: 2017-04-10.
Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, Griffin ML, Gourevitch MN, Haller DL, Hasson HL, Huang Z, Jacobs P, Kosinski AS, Lindblad R, McCance-Katz EF, Provost SE, Selzer J, Somoza EC, Sonne SC, Ling W. Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence. Arch Gen Psychiatry. 2012; 68(12): 1238-1246. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470422/ Accessed on: 2017-05-23.
